(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CANSINOBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CANSINOBIO

ST13

US500000098189642

Class

5

Filing

98189642

Registration

7526930

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

04/03/2026

Trademark type

Combined

Nice classes

5

Filing date

09/20/2023

Registration date

10/08/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/08/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

Tianjin, CN

Examiner

ZELLNER, SIERRA E

Law office

O50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of stylized letters "CANSINOBIO".

Holders and representatives

Holders

CANSINO BIOLOGICS INC.

Representatives

Paulo A. de Almeida PATEL & ALMEIDA PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsantivirals; Chemical preparations for pharmaceutical purposesfor the treatment of infectious diseases; Vaccines; Medicines for the treatment of infectious diseases; Cultures of microorganisms for medical or veterinary use; Chemical preparations for medical purposesfor the treatment of infectious diseases; Injectable pharmaceuticals for treatment of anaphylactic reactions; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biochemical medicines for the treatment of infectious diseasesbiochemical reagents for medical purposes; Bacteriological culture mediums

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/08/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/08/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/23/2024

PUBO

PUBLISHED FOR OPPOSITION

07/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/18/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/13/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/13/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/13/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/20/2024

GNRT

NON-FINAL ACTION E-MAILED

05/20/2024

CNRT

NON-FINAL ACTION WRITTEN

05/20/2024

DOCK

ASSIGNED TO EXAMINER

05/14/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/07/2023

NWAP

NEW APPLICATION ENTERED

09/23/2023

Continuous trademark protection

Get notified about every new filing that threatens CANSINOBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.